Showing 1–7 of 7 results
-
Amendments and Corrections |
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
- Thomas Powles
- , Mark Kockx
- , Alejo Rodriguez-Vida
- , Ignacio Duran
- , Simon J. Crabb
- , Michiel S. Van Der Heijden
- , Bernadett Szabados
- , Albert Font Pous
- , Gwenaelle Gravis
- , Urbano Anido Herranz
- , Andrew Protheroe
- , Alain Ravaud
- , Denis Maillet
- , Maria Jose Mendez
- , Cristina Suarez
- , Mark Linch
- , Aaron Prendergast
- , Pieter-Jan van Dam
- , Diana Stanoeva
- , Sofie Daelemans
- , Sanjeev Mariathasan
- , Joy S. Tea
- , Kelly Mousa
- , Romain Banchereau
- & Daniel Castellano
-
Amendments and Corrections |
Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
- David F. McDermott
- , Mahrukh A. Huseni
- , Michael B. Atkins
- , Robert J. Motzer
- , Brian I. Rini
- , Bernard Escudier
- , Lawrence Fong
- , Richard W. Joseph
- , Sumanta K. Pal
- , James A. Reeves
- , Mario Sznol
- , John Hainsworth
- , W. Kimryn Rathmell
- , Walter M. Stadler
- , Thomas Hutson
- , Martin E. Gore
- , Alain Ravaud
- , Sergio Bracarda
- , Cristina Suárez
- , Riccardo Danielli
- , Viktor Gruenwald
- , Toni K. Choueiri
- , Dorothee Nickles
- , Suchit Jhunjhunwala
- , Elisabeth Piault-Louis
- , Alpa Thobhani
- , Jiaheng Qiu
- , Daniel S. Chen
- , Priti S. Hegde
- , Christina Schiff
- , Gregg D. Fine
- & Thomas Powles
-
Research | | Open
-
Research | | Open
Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib
- Arancha Cebrián
- , Teresa Gómez del Pulgar
- , María José Méndez-Vidal
- , María Luisa Gonzálvez
- , Nuria Lainez
- , Daniel Castellano
- , Iciar García-Carbonero
- , Emilio Esteban
- , Maria Isabel Sáez
- , Rosa Villatoro
- , Cristina Suárez
- , Alfredo Carrato
- , Javier Munárriz-Ferrándiz
- , Laura Basterrechea
- , Mirta García-Alonso
- , José Luis González-Larriba
- , Begoña Perez-Valderrama
- , Josefina Cruz-Jurado
- , Aránzazu González del Alba
- , Fernando Moreno
- , Gaspar Reynés
- , María Rodríguez-Remírez
- , Valentina Boni
- , Ignacio Mahillo-Fernández
- , Yolanda Martin
- , Andrea Viqueira
- & Jesús García-Foncillas
-
Research |
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
- Thomas Powles
- , Mark Kockx
- , Alejo Rodriguez-Vida
- , Ignacio Duran
- , Simon J. Crabb
- , Michiel S. Van Der Heijden
- , Bernadett Szabados
- , Albert Font Pous
- , Gwenaelle Gravis
- , Urbano Anido Herranz
- , Andrew Protheroe
- , Alain Ravaud
- , Denis Maillet
- , Maria Jose Mendez
- , Cristina Suarez
- , Mark Linch
- , Aaron Prendergast
- , Pieter-Jan van Dam
- , Diana Stanoeva
- , Sofie Daelemans
- , Sanjeev Mariathasan
- , Joy S. Tea
- , Kelly Mousa
- , Romain Banchereau
- & Daniel Castellano
-
Research |
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
- David F. McDermott
- , Mahrukh A. Huseni
- , Michael B. Atkins
- , Robert J. Motzer
- , Brian I. Rini
- , Bernard Escudier
- , Lawrence Fong
- , Richard W. Joseph
- , Sumanta K. Pal
- , James A. Reeves
- , Mario Sznol
- , John Hainsworth
- , W. Kimryn Rathmell
- , Walter M. Stadler
- , Thomas Hutson
- , Martin E. Gore
- , Alain Ravaud
- , Sergio Bracarda
- , Cristina Suárez
- , Riccardo Danielli
- , Viktor Gruenwald
- , Toni K. Choueiri
- , Dorothee Nickles
- , Suchit Jhunjhunwala
- , Elisabeth Piault-Louis
- , Alpa Thobhani
- , Jiaheng Qiu
- , Daniel S. Chen
- , Priti S. Hegde
- , Christina Schiff
- , Gregg D. Fine
- & Thomas Powles
-
Research | | Open
